Venture Certified
| 기술평가보증기업(기금) | 2020-10-19 ~ 2022-10-18 | 20200113479 | 2020-10-19 |
| 혁신성장유형 | 2022-10-19 ~ 2025-10-18 | 20221110030068 | 2020-10-19 |
| 혁신성장유형 | 2025-10-19 ~ 2028-10-18 | 20251217030038 | 2020-10-19 |
Revenue CAGR -63.2%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 0.1B | 0.1B | 0.9B |
| Operating Profit | -13.7B | -11.8B | -5.9B |
| Net Profit | -3.2B | -4.0B | -2.0B |
| Total Assets | 11.7B | 12.8B | 10.6B |
| Total Liabilities | 10.0B | 7.9B | 1.8B |
| Total Equity | 1.7B | 4.9B | 8.8B |
Debt Ratio 589.0%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -14B
3 Consecutive Years of Net Loss
Debt Ratio Surge (+426pp YoY)
▼ 76.4%
▼ 55.0%
▼ 137.2%
▲ 542.7%
▼ 256.6%
| Name | Position | Role |
|---|---|---|
| 김정석 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "경기 성남시",
"ceo_name": "김정석",
"certificate": [
{
"cert_number": "20200113479",
"changes": "",
"disclosure_date": "2020-10-19",
"first_cert_date": "2020-10-19",
"no": "1",
"type": "기술평가보증기업(기금)",
"valid_period": "2020-10-19 ~ 2022-10-18"
},
{
"cert_number": "20221110030068",
"changes": "",
"disclosure_date": "2022-11-10",
"first_cert_date": "2020-10-19",
"no": "2",
"type": "혁신성장유형",
"valid_period": "2022-10-19 ~ 2025-10-18"
},
{
"cert_number": "20251217030038",
"changes": "",
"disclosure_date": "2025-12-17",
"first_cert_date": "2020-10-19",
"no": "3",
"type": "혁신성장유형",
"valid_period": "2025-10-19 ~ 2028-10-18"
}
],
"company_name": "주식회사 셀리코",
"corp_no": "131111-*******",
"financials": {
"2022": {
"capital_stock": 68485000,
"cost_of_sales": 0,
"current_assets": 602159000,
"current_liabilities": 129572000,
"gross_profit": 90909000,
"net_income": -201128000,
"net_income_bs": -201128000,
"non_current_assets": 458683000,
"non_current_liabilities": 50863000,
"non_operating_expenses": 2013000,
"non_operating_income": 391436000,
"operating_profit": -590551000,
"revenue": 90909000,
"sga_expenses": 681460000,
"total_assets": 1060842000,
"total_equity": 880407000,
"total_liabilities": 180435000
},
"2023": {
"capital_stock": 68484000,
"cost_of_sales": 0,
"current_assets": 507188000,
"current_liabilities": 694308000,
"gross_profit": 13500000,
"net_income": -397142000,
"net_income_bs": -397142000,
"non_current_assets": 769567000,
"non_current_liabilities": 96606000,
"non_operating_expenses": 15567000,
"non_operating_income": 800671000,
"operating_profit": -1182246000,
"revenue": 13500000,
"sga_expenses": 1195746000,
"total_assets": 1276755000,
"total_equity": 485841000,
"total_liabilities": 790914000
},
"2024": {
"capital_stock": 68484000,
"cost_of_sales": 0,
"current_assets": 168178000,
"current_liabilities": 154561000,
"gross_profit": 12318000,
"net_income": -316237000,
"net_income_bs": -316237000,
"non_current_assets": 1000438000,
"non_current_liabilities": 844451000,
"non_operating_expenses": 21689000,
"non_operating_income": 1079613000,
"operating_profit": -1374161000,
"revenue": 12318000,
"sga_expenses": 1386479000,
"total_assets": 1168616000,
"total_equity": 169604000,
"total_liabilities": 999012000
}
},
"industry": "그 외 기타 의료용 기기 제조업",
"investment": [],
"main_products": "의료기기, 인공망막",
"phone": "031-778-****",
"years": [
2024,
2023,
2022
]
}